SARAH VERBURG: Open Payments
NPI 1689773301 · HASTINGS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$695 in 44 payments from 13 companies in 2025. Trend: 2023 $650 · 2024 $740 · 2025 $695
Food & beverage: $695
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 22 | $294 |
| Astellas Pharma US Inc | 4 | $85 |
| Amgen Inc. | 4 | $63 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $41 |
| ABBVIE INC. | 2 | $36 |
| PFIZER INC. | 2 | $34 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $33 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
| Esperion Therapeutics, Inc. | 1 | $18 |
Products named: Wegovy, Veozah, Rybelsus, Ozempic, OTEZLA, TRINTELLIX, NURTEC ODT, JARDIANCE.
Industry payments across MI — which companies pay providers there.
